Who owns NEWAMSTERDAM PHARMA CO NV?
- Ticker: NAMS
- CUSIP Number: n62509109
Tip: Access positions for across all investors
Analyze quarterly positions in Newamsterdam Pharma Co Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Newamsterdam Pharma Co Nv stock
Who bought or sold NEWAMSTERDAM PHARMA CO NV this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Frazier Life Sciences Management | 13M | $213M | 5% | Sep 2024 |
|
| Fcpm Iii Services B.v. | 12M | $227M | 0% | Jun 2024 |
|
| Bain Capital Life Sciences Investors | 11M | $201M | 0% | Jun 2024 |
|
| RA Capital Management | 8.1M | $134M | 0% | Sep 2024 |
|
| Viking Global Investors | 8.0M | $133M | 0% | Sep 2024 |
|
| Medicxi Ventures Management | 2.9M | $48M | 0% | Sep 2024 |
|
| Cormorant Asset Management | 2.3M | $44M | 53% | Jun 2024 |
|
| BVF | 1.5M | $25M | 0% | Sep 2024 |
|
| Woodline Partners | 1.2M | $19M | 141% | Sep 2024 |
|
| Jennison Associates | 1.0M | $17M | 9% | Sep 2024 |
|
| Henderson Group | 1.0M | $20M | 60% | Jun 2024 |
|
| Pictet Asset Management Holding SA | 1.0M | $17M | 57% | Sep 2024 |
|
| Siren | 921k | $15M | 100% | Sep 2024 |
|
| Deerfield Management Company | 902k | $15M | 4% | Sep 2024 |
|
| Avidity Partners Management | 890k | $15M | 59% | Sep 2024 |
|
| Decheng Capital | 590k | $9.8M | 48% | Sep 2024 |
|
| Citadel Advisors | 543k | $9.0M | 149% | Sep 2024 |
|
| Affinity Asset Advisors | 472k | $7.8M | 12% | Sep 2024 |
|
| Arrowpoint Asset Management | 355k | $5.9M | 19% | Sep 2024 |
|
| Opaleye Management | 335k | $5.6M | 6% | Sep 2024 |
|
| Alyeska Investment Group | 308k | $5.1M | 260% | Sep 2024 |
|
| Duquesne Family Office | 288k | $4.8M | 100% | Sep 2024 |
|
| TimesSquare Capital Management | 255k | $4.2M | 4% | Sep 2024 |
|
| Ensign Peak Advisors | 246k | $4.1M | 0% | Sep 2024 |
|
| Moody Aldrich Partners | 217k | $3.6M | -2% | Sep 2024 |
|
| HealthInvest Partners AB | 139k | $2.3M | 521% | Sep 2024 |
|
| Parkman Healthcare Partners | 135k | $2.6M | -32% | Jun 2024 |
|
| Standard Life Aberdeen | 129k | $2.1M | 70% | Sep 2024 |
|
| Readystate Asset Management | 121k | $2.0M | 100% | Sep 2024 |
|
| Marshall Wace | 110k | $1.8M | 404% | Sep 2024 |
|
| Baker Bros. Advisors | 97k | $1.6M | 0% | Sep 2024 |
|
| Geode Capital Management | 86k | $1.4M | 2% | Sep 2024 |
|
| Two Sigma Investments | 86k | $1.7M | 67% | Jun 2024 |
|
| CenterBook Partners | 86k | $1.4M | 100% | Sep 2024 |
|
| ALPS Advisors | 70k | $1.2M | 100% | Sep 2024 |
|
| BlackRock | 67k | $1.1M | 100% | Sep 2024 |
|
| GSA Capital Partners | 66k | $1.1M | 80% | Sep 2024 |
|
| Superstring Capital Management | 64k | $1.2M | 100% | Jun 2024 |
|
| Artia Global Partners | 54k | $901k | 0% | Sep 2024 |
|
| AH Lisanti Capital Growth | 42k | $700k | 100% | Sep 2024 |
|
| BlackRock | 42k | $800k | 271% | Jun 2024 |
|
| Hrt Financial | 38k | $624k | 100% | Sep 2024 |
|
| J. Goldman & Co | 37k | $707k | -53% | Jun 2024 |
|
| Swiss National Bank | 35k | $583k | 0% | Sep 2024 |
|
| Ikarian Capital | 29k | $483k | 100% | Sep 2024 |
|
| Glenmede Trust Company | 27k | $455k | 117% | Sep 2024 |
|
| M^T Bank Corporation | 27k | $454k | 54% | Sep 2024 |
|
| Goldman Sachs Group | 25k | $488k | -98% | Jun 2024 |
|
| Morgan Stanley | 25k | $474k | -86% | Jun 2024 |
|
| Yarbrough Capital | 24k | $398k | 0% | Sep 2024 |
|
| Sei Investments | 24k | $393k | 44% | Sep 2024 |
|
| Jpmorgan Chase & Co | 22k | $371k | 177% | Sep 2024 |
|
| Jane Street | 20k | $332k | 100% | Sep 2024 |
|
| D. E. Shaw & Co | 18k | $305k | 100% | Sep 2024 |
|
| Envestnet Asset Management | 18k | $300k | -6% | Sep 2024 |
|
| AQR Capital Management | 16k | $265k | 100% | Sep 2024 |
|
| California State Teachers Retirement System | 16k | $261k | -3% | Sep 2024 |
|
| Us Bancorp | 14k | $239k | 0% | Sep 2024 |
|
| State Street Corporation | 14k | $271k | 100% | Jun 2024 |
|
| Vanguard Group | 13k | $258k | 100% | Jun 2024 |
|
| Kennedy Capital Management | 12k | $228k | 100% | Jun 2024 |
|
| Rosalind Advisors | 10k | $168k | 0% | Sep 2024 |
|
| Venture Visionary Partners | 10k | $166k | -9% | Sep 2024 |
|
| Royal Bank of Canada | 9.0k | $149k | 2% | Sep 2024 |
|
| Bellevue Group | 7.7k | $128k | 100% | Sep 2024 |
|
| Atlantic Trust | 7.6k | $127k | -40% | Sep 2024 |
|
| Barclays | 7.6k | $126k | 1813% | Sep 2024 |
|
| Wolverine Asset Management | 4.9k | $82k | -68% | Sep 2024 |
|
| Pnc Financial Services | 4.4k | $74k | 66% | Sep 2024 |
|
| Bank of America Corporation | 2.7k | $45k | -14% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 2.4k | $41k | 100% | Sep 2024 |
|
| Parallel Advisors | 1.4k | $23k | 40% | Sep 2024 |
|
| Bradley & Co. Private Wealth Management | 729.00 | $14k | 0% | Jun 2024 |
|
| Signature | 647.00 | $11k | 0% | Sep 2024 |
|
| PSI Advisors | 500.00 | $8.3k | 0% | Sep 2024 |
|
| Wells Fargo & Company | 500.00 | $8.3k | 0% | Sep 2024 |
|
| Stone House Investment Management | 325.00 | $5.4k | 0% | Sep 2024 |
|
| Quarry | 253.00 | $4.9k | 100% | Jun 2024 |
|
| Advisor Group Holdings | 187.00 | $3.1k | 100% | Sep 2024 |
|
| Global Retirement Partners | 91.00 | $1.5k | -77% | Sep 2024 |
|
| Simplex Trading | 62.00 | $999.998000 | 100% | Sep 2024 |
|
| CWM | 38.00 | $1.0k | 100% | Sep 2024 |
|
| Principal Securities | 23.00 | $382.000100 | 360% | Sep 2024 |
|
| DuPont Capital Management Corporation | 1.00 | $17.000000 | 0% | Sep 2024 |
|
Who sold out of Newamsterdam Pharma Co Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 1.2M | $22M |
| Artal Group | Jun 2024 | 800k | $15M |
| Silverarc Capital Management | Mar 2024 | 100k | $2.4M |
| Schonfeld Strategic Advisors | Jun 2024 | 49k | $950k |
| Vestal Point Capital | Jun 2024 | 25k | $480k |
| Y-Intercept | Jun 2024 | 15k | $281k |
| Parkwood | Jun 2024 | 14k | $265k |
| Two Sigma Advisers | Mar 2024 | 9.1k | $215k |
| Banque Cantonale Vaudoise | Jun 2024 | 2.0k | $38k |
| Canton Hathaway | Mar 2024 | 1.0k | $24k |